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Abstract: Ultraviolet (UV) filters are chemicals widely used in personal care products (PCPs). Due to
their effect as endocrine disruptor compounds (EDCs), the toxicity of UV filters is a current concern
for human health. EDC exposure may be correlated to cardiovascular diseases (CVD), but to
our knowledge, no studies assessed the UV filters effects as human EDCs at the vascular level.
Octylmethoxycinnamate (OMC) is the world’s most widely used UV-B filter, present in more than
90% of PCPs. Due to its demonstrated multiple hormonal activities in animal models, this substance
is also suspected to be a human EDC. The purpose of this study was to assess the rapid/short-term
effects of OMC on arterial tonus and analyse its mode of action (MOA). Using human umbilical
arteries, the endocrine effects of OMC were evaluated in in vitro (cellular and organ) experiments
by planar cell surface area (PCSA) and organ bath, respectively. Our data show that OMC induces
a rapid/short-term smooth muscle relaxation acting through an endothelium-independent MOA,
which seems to be shared with oestrogens, involving an activation of soluble guanylyl cyclase (sGC)
that increases the cyclic guanosine monophosphate (cGMP) intracellular levels and an inhibition of
L-type voltage-operated Ca2+ channels (L-Type VOCC).
Keywords: UV-B filter; endocrine disruptor compound; human umbilical artery; vascular smooth
muscle cells; relaxation; L-Type VOCC; soluble guanylyl cyclase; organ bath; planar cell surface area
1. Introduction
Ultraviolet (UV)-B filters are chemical substances widely used in personal care products (PCPs),
which can act as endocrine disruptor compounds (EDCs) [1,2]. Due to their capacity to interfere with
endogenous hormones [3,4], the toxicity of these EDCs is a current concern for human health, mainly
in early stages of development such as in embryos, foetuses, infants and children [5–7]. Since the
endocrine system controls many maturation processes of organisms (including gestation, infancy and
childhood) [6,7], it is crucial to assess the effects of these compounds on human fluids or tissues.
Human umbilical artery (HUA) is a human vascular model to study cardiovascular diseases
(CVD) [8], allowing the study of the effect of EDCs, like UV-B filters, on vascular functions of pregnant
women and foetuses. HUA is involved in fetoplacental circulation and is an excellent source of
vascular smooth muscle cells (SMC) [8,9]. Due to their specific physiological regulation, in vitro
studies concerning the intracellular mechanisms modulating HUA contractility are of great importance.
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These studies may lead to a better understanding of several vascular diseases, mainly hypertension in
pregnancy or preeclampsia [8]. Nowadays, many research groups are working to correlate human
exposure to EDCs and cardiovascular diseases (CVD) [5,10–12]. However, to the best of our knowledge
no studies were performed to explore the mode of action (MOA) of UV-B filters as human EDCs and
to understand their involvement in vascular diseases.
Octylmethoxycinnamate (OMC) is the world’s most widely used UV-B filter [13]. This substance
is suspected to be an EDC [14,15] due to its demonstrated interaction with oestrogen, androgen,
progesterone and thyroid receptors [16]. Studies on the toxicity of this UV-B filter were focused
primarily on animal models and demonstrated multiple hormonal activities: oestrogenic [14,15,17–23],
antiandrogenic [24–26], antiprogestenic [17,25] and antithyroid [19,25,27–29]. However, toxicity studies
of OMC in humans are scarce.
This issue is of special importance because, as a UV-B filter, OMC can bioaccumulate in the
aquatic ecosystems [30,31] and has greater environmental repercussions with potential risks to human
health [16,32]. For instance, recently the US state of Hawaii has banned sunscreens containing OMC
due the potential risks posed to corals [33]. Moreover, it has been demonstrated that OMC can be
transmitted to the zebrafish offspring and produce toxic effects (by parental transfer) [31]—findings
that support our hypothesis that toxic effects of OMC might also be observed in humans.
In this context, and due to their widespread presence in a large number of PCPs (more than
90%) [34], in the present work, the UV-B filter octylmethoxycinnamate was selected to assess the
rapid/short-term effects on arterial tonus and to discover the underlining mechanisms involved
in these effects. To elucidate this, HUA were used in in vitro organ experiments (by organ bath
techniques) and the OMC effect was evaluated on the contracted endothelium-denuded HUA rings.
The HUA were also used to perform cultures of SMC. The HUASMC cultured were used for in vitro
cellular experiments (by planar cell surface area, PCSA), and the OMC effect on the contracted cells
was analysed.
2. Results
2.1. Effects of OMC on Arterial Contractility
The denuded-HUA rings were contracted with two different receptor agonists (serotonin, 5-HT or
histamine, His) or by depolarisation with isosmotic KCl (60 mmol/L) solution, to analyse their
sensitivity. The maximum contractile effects elicited by 5-HT, His and KCl were 1737 ± 574 mg (n = 18),
1054 ± 424 mg (n = 21) and 1578 ± 658 mg (n = 18), respectively, being 5-HT and KCl significantly
different from His (p < 0.05, one-way ANOVA with Tukey’s post-hoc test). Then, the OMC effect
was examined exposing the contracted arteries to different cumulative concentrations of OMC
(0.001–50 µmol/L). All vascular effects observed were reversible after washing with Krebs’ solution.
OMC induced vasorelaxation of HUA rings precontracted with either serotonin (Figure 1A),
histamine (Figure 1B) or KCl (Figure 1C). The OMC effects on 5-HT contractions were significant at
concentrations OMC of 0.1, 10 and 50 µmol/L (p < 0.05, Student t-test), evidencing a nonmonotonic
response. All OMC concentrations induced vasorelaxation when compared to the lowest one
(0.001 µmol/L) (p < 0.05, one-way ANOVA with Tukey’s post-hoc test). However, a monotonic response
was observed when His and KCl precontracted arteries were exposed to 1–50 µmol/L of OMC (p < 0.05,
Student’s t-test). For His contractions, the three highest OMC concentrations (1–50 µmol/L) caused
a significant vasorelaxation compared with the remaining concentrations (p < 0.05, one-way ANOVA
with Tukey’s post-hoc test), while in KCl contractions, the highest (50 µmol/L) OMC concentration
caused a significantly higher relaxation compared with the other concentrations used (p < 0.05, one-way
ANOVA with Tukey’s post-hoc test).
As shown in Figure 1, the maximum relaxation induced by OMC in all contractions analysed
was observed at the highest tested concentration (50 µmol/L). The relaxations elicited by OMC
(50 µmol/L) on 5-HT-, His- or KCl-contracted arteries were 11.31 ± 7.13% (n = 10), 24.44 ± 12.31%
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(n = 11) and 24.91 ± 11.36% (n = 9), respectively, His and KCl being significantly different from 5-HT
(p < 0.05, one-way ANOVA with Tukey’s post-hoc test). So, these effects may depend on the contractile
agent used. Ethanol (the solvent used to dissolve OMC) did not have significant relaxant effects on
contracted arteries at the concentrations used (Figure 1). Concerning the gender of newborns, in all the
24 denuded-HUA rings used for the arterial contractility experiments, nine were from male and 15
were from female foetuses. No gender-specific differences were observed in the OMC effects on 5-HT-,
His- or KCl-contracted arteries from males or females (p > 0.05, Student’s t-test, data not shown).
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Figure 1. Vasorelaxant effects of octylmethoxycinnamate (OMC, 0.001–50 μmol/L) on endothelium-
denuded HUA rings contracted with (A) serotonin (5-HT, 1 μmol/L), (B) histamine (His, 10 μmol/L) 
and (C) potassium chloride (KCl, 60 mmol/L). Data are expressed as percentage (%) of relaxation on 
contractile effects. The bars represent the mean values and the lines the standard deviation (S.D.) of 
the number of artery rings (n) indicated above the bars. * Represents statistical differences between 
OMC and control (p < 0.05, Student’s t-test) and # represents statistical differences between OMC 
concentrations (p < 0.05, one-way ANOVA followed by Tukey’s post-hoc tests). 
2.2. Effects of L-Type VOCC on OMC-Induced Vasorelaxation  
The denuded-HUA rings were contracted with the same agonists (1 μmol/L 5-HT or 10 μmol/L 
His) or by depolarisation with isosmotic KCl (60 mmol/L) solution, as previously described. The 
maximum contractile effects elicited by 5-HT, His and KCl were 1846 ± 158 mg (n = 16), 1046 ± 515 
mg (n = 21) and 1715 ± 530 mg (n = 13), respectively, 5-HT and KCl being significantly different from 
His (p < 0.05, Kruskal–Wallis by ranks with Dunn’s post-hoc test). The contracted arteries were 
exposed to a specific inhibitor of L-Type VOCC (nifedipine, Nif) and the OMC-induced 
vasorelaxation (OMC; 0.001–50 μmol/L) was examined. Nif (0.1 and 1 μmol/L) was used to analyse 
the involvement of this type of Ca2+ channels in the relaxing effect mediated by OMC. After washing 
out with Krebs’ solution all observed vascular effects were revered.  
As shown in the Figure 2, Nif caused vasorelaxation in all contractions analysed. The maximum 
relaxant effects elicited by Nif on 5-HT-, His- and KCl-contracted arteries were 79.47 ± 13.51% (n = 7), 
63.99  ± 15.90% (n = 9) and 85.31 ±  7.64% (n = 5), respectively. The KCl-contracted HUA induced its 
contraction due to the influx of extracellular Ca2+, because of depolarisation and opening of voltage-
dependent channels (mainly L-Type VOCC). For this reason, Nif 1 μmol/L (a specific blocker of L-
type VOCC) induced a relaxation close to 100% (data not shown), so we used a lower concentration 
Figure 1. Vasorelaxant effects of octylmethoxycinnamate (OMC, 0.001–50 µmol/L) on
endothelium-denuded HUA rings contracted with (A) serotonin (5-HT, 1 µmol/L), (B) histamine
(His, 10 µmol/L) and (C) potassium chloride (KCl, 60 mmol/L). Data are expressed as percentage
(%) of relaxation on contractile effects. The bars represent the mean values and the lines the standard
deviation (S.D.) of the number of artery rings (n) indicated above the bars. * Represents statistical
differences between OMC and control (p < 0.05, Student’s t-test) and # represents statistical differences
between OMC concentrations (p < 0.05, one-way ANOVA followed by Tukey’s post-hoc tests).
2.2. Effects of L-Type VOCC on OMC-Induced Vasorelaxation
The denuded-HUA rings were contracted with the same agonists (1 µmol/L 5-HT or 10 µmol/L
His) or by depolarisation with isosmotic KCl (60 mmol/L) solution, as previously described.
The maximum contractile effects elicited by 5-HT, His and KCl were 1846 ± 158 mg (n = 16),
1046 ± 515 mg (n = 21) and 1715 ± 530 mg (n = 13), respectively, 5-HT and KCl being significantly
different from His (p < 0.05, Kruskal–Wallis by ranks with Dunn’s post-hoc test). The contracted
arteries were exposed to a specific inhibitor of L-Type VOCC (nifedipine, Nif) and the OMC-induced
vasorelaxation (OMC; 0.001–50 µmol/L) was examined. Nif (0.1 and 1 µmol/L) was used to analyse
the involvement of this type of Ca2+ channels in the relaxing effect mediated by OMC. After washing
out with Krebs’ solution all observed vascular effects were revered.
As shown in the Figure 2, Nif caused vasorelaxation in all contractions analysed. The maximum
relaxant effects elicited by Nif on 5-HT-, His- and KCl-contracted arteries were 79.47 ± 13.51% (n = 7),
63.99 ± 15.90% (n = 9) and 85.31 ± 7.64% (n = 5), respectively. The KCl-contracted HUA induced
its contraction due to the influx of extracellular Ca2+, because of depolarisation and opening of
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voltage-dependent channels (mainly L-Type VOCC). For this reason, Nif 1 µmol/L (a specific blocker
of L-type VOCC) induced a relaxation close to 100% (data not shown), so we used a lower concentration
0.1 µmol/L to better analyse a possible additive effect of the joint use of OMC and Nif. Regardless
of the contractile stimuli, the vasorelaxation induced by the joint application of Nif and OMC was
significantly different from the individual OMC effect and similar to the individual Nif effect (p > 0.05,
one-way ANOVA with Tukey’s post-hoc test or Kruskal–Wallis by ranks with Dunn’s post-hoc test).
These results suggest that the OMC relaxant effect is mediated by inactivation of L-Type VOCC.
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and the lines the standard deviation (S.D.) of the number of artery rings (n) indicated above the bars. 
* Represent statistical differences between OMC and Nif + OMC (p < 0.05) and # represents statistical 
differences between Nif and Nif + OMC (p < 0.05), one-way ANOVA method followed by Tukey’s 
post-hoc tests or the corresponding nonparametric method the Kruskal–Wallis followed by Dunn’s 
post-hoc tests. 
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For the denuded-HUA rings, contraction the same receptor agonists (5-HT; 1 μmol/L or His; 10 
μmol/L) or by depolarisation with isosmotic KCl (60 mmol/L) solution were used once more. The 
maximum contractile effects elicited by 5-HT, His and KCl were 1754 ± 720 mg (n = 15), 945 ± 355 mg 
(n = 14) and 1725 ± 330 mg (n = 12), respectively, 5-HT and KCl being different from His (p < 0.05, 
Kruskal–Wallis by ranks with Dunn’s post-hoc test). The contracted arteries were exposed to a 
stimulator of sGC, the sodium nitroprusside (SNP) and the OMC-induced vasorelaxation (OMC; 
0.001–50 μmol/L) was examined. SNP (1 and 10 μmol/L) was used to analyse the involvement of this 
pathway in the relaxing effect mediated by OMC. After washing out with Krebs’ solution all observed 
vascular effects were reversed.  
As shown in Figure 3, SNP caused vasorelaxation in all contractions analysed. The maximum 
relaxant effects elicited by SNP on 5-HT-, His- and KCl-contracted arteries were 52.05  ±  20.10% (n = 
7), 82.19 ± 8.04% (n = 6) and 70.09 ± 6.57% (n = 5), respectively. As for His-contracted HUA, 10 μmol/L 
of SNP induced a relaxation close to 100% (data not shown), for this reason we used a lower 
Figure 2. Vasorelaxant effects of octylmethoxycinnamate (OMC, 0.001–50 µmol/L), nifedipine
(Nif, 1 µmol/L) and Nif plus OMC on endothelium-denuded HUA rings contracted with (A) serotonin
(5-HT, 1 µmol/L), (B) histamine (His, 10 µmol/L) and (C) potassium chloride (KCl, 60 mmol/L).
Data are expressed as percentage (%) of relaxation on contractile effects. The bars represent the mean
values and the lines the standard deviation (S.D.) of the number of artery rings (n) indicated above
the bars. * Represent statistical differences between OMC and Nif + OMC (p < 0.05) and # represents
statistical differences between Nif and Nif + OMC (p < 0.05), one-way ANOVA method followed by
Tukey’s post-hoc tests or the corresponding nonparametric method the Kruskal–Wallis followed by
Dunn’s post-hoc tests.
2.3. Effects f cGMP on OMC-Induced Vasorelaxation
For the denuded-HUA rings, contraction the same receptor agonists (5-HT; 1 µmol/L or His;
10 µmol/L) or by depolarisation with isosmotic KCl (60 mmol/L) solution were used once more.
The maximum contractile effects elicited by 5-HT, His and KCl were 1754 ± 720 mg (n = 15),
945 ± 355 mg (n = 14) and 1725 ± 330 mg (n = 12), respectively, 5-HT and KCl being differ nt from His
(p < 0.05, Krusk l–Wallis by ranks with Dunn’s post-hoc test). The contracted arteries were exposed
to a stimulator of sGC, the sodium nitro russide (SNP) and the OMC-in uced vasorelaxation (OMC;
0.001–50 µmol/L) was examined. SNP (1 and 10 µmol/L) was used to analyse the involvement of this
pathw y in the relaxing effect ediated by OMC. After was ing out with Krebs’ solution all observed
vascular effects were reversed.
As shown in Figure 3, SNP caused vasorelaxation in all contractions analysed. The maximum
relaxant effects elicited by SNP on 5-HT-, His- and KCl-contracted arteries were 52.05 ± 20.10% (n = 7),
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82.19 ± 8.04% (n = 6) and 70.09 ± 6.57% (n = 5), respectively. As for His-contracted HUA, 10 µmol/L of
SNP induced a relaxation close to 100% (data not shown), for this reason we used a lower concentration
1 µmol/L to better analyse a possible additive effect of the joint use of OMC and SNP. Regardless
of the contractile stimuli, the vasorelaxation induced by the joint application of SNP and OMC was
significantly different from the individual OMC effect and similar to the individual SNP effect (p > 0.05,
one-way ANOVA with Tukey’s post-hoc test or Kruskal–Wallis by ranks with Dunn’s post-hoc test).
These results suggest that the OMC relaxant effect is mediated by activation of sGC, with increases of
cGMP levels.
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Figure 3. Vasorelaxant effects of octylmethoxycinnamate OMC (0.001–50 µmol/L), sodium
nitroprusside (SNP, 10 or 1 µmol/L) and SNP plus OMC on endothelium-denuded HUA rings
contracted with (A) serotonin (5-HT, 1 µmol/L), (B) histamine (His, 10 µmol/L) and (C) potassium
chloride (KCl, 60 mmol/L). Data are expressed as percentage (%) of relaxation on contractile effects.
The bars represent the mean values and the lines the standard deviation (S.D.) of the number of artery
rings (n) indicated above the bars. * Represent statistical differences between OMC and SNP + OMC
(p < 0.05) and # represents statistical differences between SNP concentrations and SNP + OMC (p < 0.05),
one-way ANOVA followed by Tukey’s post-hoc tests or the corresponding nonparametric method the
Kruskal–Wallis followed by Dunn’s post-hoc tests).
2.4. Eff cts of OMC on Cellular Contractility
HUASMC were contracted by two different receptor agonists (5-HT; 1 µmol/L or His; 10 µmol/L).
The maximum contractile effects elicited by 5-HT and His were 27.431 ± 4.729 µm2 (n = 6) and
28.447 ± 7.783 µm2 (n = 7), respectively. The contracted cells were exposed to a concentration of OMC
(50 µmol/L), and the direct effect of OMC on these contractions was examined. The changes in the
area of HUASMC were quantified over the time, and in the presence and absence of the different drugs
and agents used.
After incubation with OMC, a relaxation of the HUASMC was evident (p < 0.05, Student’s t-test)
in cells precontracted either by 5-HT (Figure 4A) or by His (Figure 4B). The relaxing effect elicited by
OMC on 5-HT- or His-precontracted cells were 35.767 ± 10.218 µm2 (n = 5) and 34.898 ± 9.626 µm2
(n = 6), respectively. Ethanol (the solvent used to dissolve OMC) did not have significant effects on
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the contracted cells at the concentrations used (Figure 4). As shown in Figure 5, the relaxation data
obtained were similar for both contractile agents used (p > 0.05, Student’s t-test).
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with (A) serotonin (5-HT, 1 μmol/L) and (B) histamine (His, 10 μmol/L). Data are expressed as 
percentage (%) of relaxation on area induced by each contractile agent. The bars represent the mean 
values and the lines the standard deviation (S.D.) of the number (n) of human umbilical arteries 
indicated above the bars. * Represents statistical differences between OMC concentration and control 
(p < 0.05, Student’s t-test). 
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3. Discussion 
Octylmethoxycinnamate is the world’s most widely used UV-B filter [13]. This substance is 
suspected to be an EDC [14,15] due to its demonstrated interaction with oestrogen, androgen, 
progesterone and thyroid receptors [16]. However, to date, and to the best of our knowledge, there 
are no studies performed on human blood vessels. One question remains unanswered: How does 
OMC act on human arteries contractility? This work aimed to analyse the effect of OMC at the 
vascular level, and with it we demonstrated for the first time that OMC is a vasodilator of human 
umbilical arteries.  
Using the organ bath technique, firstly, we studied the rapid/short-term effects of OMC on 
contracted endothelium-denuded HUA. The vascular endothelium was previously removed 
(because our proposal was to study the effect of OMC at the smooth muscle level) and then 
cumulative concentrations of OMC (0.001–50 μmol/L) were administered to HUA contracted either 
with 5-HT, His and KCl (60 mmol/L). As expected, and in accordance with other authors [35,36], our 
results showed similar maximum contractions induced by 5-HT and KCl (60 mmol/L) in HUA. 
Nevertheless, other investigators indicated that contractions caused by 5-HT may be higher than 
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Figure 5. Vasorelaxant effects of octylmethoxycinnamate (OMC, 50 µmol/L) on HUASMC contracted
with serotonin (5-HT, 1 µmol/L) and histamine (His, 10 µmol/L). Data are expressed as percentage (%)
of relaxation on the area induced by each contractile agent. The bars represent the mean values and the
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3. Discussion
Octylmethoxycinnamate is the world’s most widely used UV-B filter [13]. This substance
is suspected to be an EDC [14,15] due to its demonstrated interaction with oestrogen, androgen,
progesterone and thyroid receptors [16]. However, to date, and to the best of our knowledge, there are
no studies performed on human blood vessels. One question remains unanswered: How does OMC
act on human arteries contractility? This work aimed to analyse the effect of OMC at the vascular level,
and with it we demonstrated for the first time that OMC is a vasodilator of human umbilical arteries.
Using the organ bath techniq , firs ly, we studied the pid/short-term eff cts of OMC
on con racted endothelium-d nuded HUA. The vascular endo helium was previously remov d
(because our proposal was to study the eff ct of MC at the smooth muscle l vel) and then
cumulative concentrations of OMC (0.001–50 µmol/L) were administered to HUA contracted either
with 5-HT, His KCl (60 mmol/L). As expected, and in accordance with other authors [35,36],
our results showed similar maximum contractions induced by 5-HT and KCl (60 mmol/L) in
HUA. Nevertheless, other investigators indicated that contractions caused by 5-HT may be higher
tha those induced by KCl (60 mmol/L) [37]. The tension pr duced by His was l wer than that
caused by 5-HT, which is in g od agreement with previous studie of Quan et al. (2003) [38] and
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Cairrao et al. (2008) [36], and by KCl (60 mmol/L). Concerning the maximum OMC-associated
effects, as already mentioned, these effects in human arteries are not described in the literature.
Results from present work demonstrate for the first time that OMC induces a rapid/short-term
and concentration-dependent relaxation of denuded HUA rings contracted with either 5-HT, His or
KCl (60 mmol/L). Furthermore, we observed that OMC effects were rapid and reversible, as they
disappeared after drug washing. Because the OMC effects were observed in the absence of the
endothelium, we can conclude that this vasorelaxant effect is not due to nitric oxide (NO) production,
therefore being endothelium-independent. On the other hand, the maximum relaxation induced by
OMC in all contractions analysed was observed for the highest concentration tested (50 µmol/L).
However, the vasorelaxation in arteries contracted with 5-HT was less pronounced that the effect
induced on the arteries contracted with His or KCl (60 mmol/L), where the maximum relaxation
achieved was similar. So, these results suggest that effects of OMC were dependent on the contractile
agent used. This difference could give some indications as to what MOA might be involved in
OMC-induced relaxation. Furthermore, as can be explained based on the different mechanisms
involved in the contractile effects of each of these agents, the 5-HT pathway, in the contraction of HUA
without endothelium, involves the activation of 5-HT2A receptors (coupled to Gq protein) and partial
activation of 5-HT1B/5-HT1D (coupled to Gi/o protein) present in the smooth muscle of this artery.
Activation of these receptors leads to muscle contraction [39,40]. In the case of His, contraction is
achieved by the activation of H1 receptors. This receptor, coupled to Gq protein, activates the PLC/IP3
signalling cascade, leading to an increase in intracellular Ca2+ levels and consequent contraction [40–42].
Schneider et al. (2004) also reported the expression of the H2 receptor in HUA smooth muscle [43].
This receptor, coupled to Gs protein, stimulates adenyl cyclase, leading to an increase in cAMP levels
and consequent relaxation. Although the effect of activation of the H1 receptor seems to predominate,
the effect of His may also be influenced by the activation of the H2 receptor, causing less potent
contractions. For this reason, we can hypothesise that OMC relaxation in HUA may be due to the
action of UV-B filter in the H1 or H2 receptors and involves Ca2+ channels inhibition or K+ channel
activation. Consistently, the data for 5-HT-contracted HUA seems to indicate that the OMC effect is due
to modulation of the 5-HT2A or 5-HT1B/5-HT1D receptors and involves Ca2+ channels inhibition or K+
channels activation. With respect to KCl, the vascular contraction induced by this agent is mainly due to
the influx of extracellular Ca2+, because of depolarisation and opening of voltage-dependent channels
(mainly L-Type VOCC) [37]. These channels open and increase intracellular Ca2+ concentration [Ca2+]I
resulting in muscle contraction [44]. Thus, taking into account that [Ca2+]I is a key to HUA vascular
smooth muscle contraction/relaxation [8], our results seem to be consistent with the inhibition of
L-Type VOCC as the main pathway involved in the OMC vasorelaxation.
Consequently, to check this pathway, the next step was to analyse the MOA of OMC,
exploring the role of this type Ca2+ channels on OMC-induced vasorelaxation. For this, contracted
endothelium-denuded HUA rings by different stimuli were exposed to a specific inhibitor of L-Type
VOCC (nifedipine, Nif) and the OMC-induced vasorelaxation was examined. As expected, and in
accordance with other authors (Saldanha et al., 2013) [45], our results showed that Nif induces
relaxation on HUA precontracted with 5-HT, His or KCl (60 mmol/L). However, the fact that Nif 1 µM
induces total relaxation of KCl-contracted HUA (data not shown) led us to use a lower concentration of
Nif (0.1 µmol/L) to better analyse a possible additive effect of the joint use of OMC and Nif. Moreover,
and despite being not statistically different, it was visible that the maximum relaxant effects elicited
by Nif 0.1 µmol/L on KCl-contracted arteries remained slightly larger than the effects elicited by
Nif 1 µmol/L on contracted arteries with 5-HT and His. Therefore, these results confirm that the
KCl-contraction is due to the opening of the L-Type VOCC. Concerning the OMC-associated effects,
independently of the contractile stimuli, it was evident that the vasorelaxation induced by the joint
application of Nif and OMC was significantly different from the individual OMC-induced effect
and was similar to the individual Nif-induced effect. These data support the idea that OMC can
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have the same MOA as Nif, or act through an interconnected pathway that involves inactivation of
voltage-dependent Ca2+ channels, L-Type VOCC.
Several studies have reported an oestrogenic activity for OMC [14,15,17–23]. Currently,
it is clear that oestrogens cause rapid vasodilation at the arterial level [46–50] and in HUA
an oestrogen-mediated vasorelaxation has been previously reported [51,52]. Specifically, it has been
demonstrated that one of the privileged pathways for oestrogen-mediated relaxation occurs through
a rapid and endothelium-independent mechanism [47,49,53], which is in good agreement with the
data we obtained. Concerning L-Type VOCC inhibition, it has also been shown that inhibition of
these Ca2+ channels is associated with oestrogen-mediated vasodilation [49,50,54,55]. For instance,
Okabe et al. (1999) demonstrated that 17β-oestradiol inhibits Ca2+ channels in SMC from pregnant rat
myometrium [50], while Zhang et al. (2002) also reported the same inhibitory effect of oestradiol on
L-Type VOCC in A7r5 cells [56]. Moreover, other authors demonstrated that 17β-oestradiol induces
rapid and endothelium-independent relaxation by inhibiting L-Type VOCC in vascular SMC [57] and
in rat aortic smooth muscle [49]. As expected, and in accordance with these authors our findings show
that OMC induces vasorelaxation by inhibition of L-type VOCC in human umbilical arteries. Hence,
the relaxing effect of OMC is endothelium-independent, and its MOA may involve the inactivation of
Ca2+ channels, L-Type VOCC. Taken together, these data have led us to create the following question.
Is the vascular MOA of OMC to induce vasorelaxation in HUA similar to that of oestrogens?
To answer this question, the next step was to analyse the MOA of OMC, exploring the role of cyclic
nucleotide (soluble guanyl ciclase, sGC) on OMC-induced vasorelaxation. This was chosen because the
activation of sGC (which increases the cGMP intracellular levels) has been proven to be one of the main
pathways by which oestrogens induce vascular relaxation [40,58]. Several authors have demonstrated
increases in cGMP levels associated with the vasodilator effects of 17β-oestradiol in human coronary
artery [59] and rat aortic artery [60]. So, to analyse this pathway, contracted endothelium-denuded
HUA rings by different stimuli were exposed to a stimulator of sGC (sodium nitroprusside, SNP)
and the OMC-induced vasorelaxation was examined. Results showed that SNP induces relaxation
on HUA precontracted either with 5-HT or His or KCl (60 mmol/L), as demonstrated in previous
HUA studies [40,58]. The SNP-induced relaxation on His-contracted arteries was larger than on 5-HT
contracted arteries, which is in accordance with previous studies of Santos-Silva et al. (2008) [40].
Concerning the OMC-associated effects, independently of the contractile stimuli, the vasorelaxation
induced by the joint application of SNP and OMC was significantly different from the individual
OMC-induced effect and was similar to the individual SNP-induced effect. These data suggest that
either SNP or OMC can have the same MOA, which involves sGC, since the effect of SNP plus OMC
does not increase. Thus, these results support our hypothesis that the MOA of OMC can be shared
with that of oestrogens, also involving activation of sGC with increases in intracellular cGMP levels.
To confirm the effects of OMC on human vasculature, the cell contractility of HUASMC was
measured by PCSA technique. Cultures of HUASMC were obtained through explants of the umbilical
artery, as described by Martin et al. (2007) [61] and Cairrao et al. (2009) [9]. The established protocol
allowed us to successfully obtain HUASMC cultures without contamination by endothelial cells
and/or fibroblasts, one of the great limitations in the establishment of SMC cultures. The HUASMC
were precontracted by two different receptor agonists (5-HT; 1 µmol/L or His; 10 µmol/L), since it
was impossible to perform the depolarisation with isosmotic KCl (60 mmol/L) solution. Then,
the contracted cells were exposed to a concentration of OMC (50 µmol/L) and the direct effect of OMC
on these contractions was examined. In the organ bath technique, we observed that OMC induces
a relaxing effect on HUA. Our PCSA data also showed for the first time a relaxing effect induced by
OMC in vascular SMC, which was similar for both contractile agents used. So, these findings support
and confirm the observed vasorelaxant effects in HUA rings.
Taken together, our data show that OMC induces rapid/short-term smooth muscle relaxation
acting through an endothelium-independent MOA that seems to be shared with oestrogens, involving
an activation of sGC with increases in the cGMP intracellular levels and an inactivation of L-Type
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VOCC. Our data are consistent with those reported in the literature, which led us to propose a model
for vascular MOA of OMC which is illustrated in Figure 6.
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4. Materials and Methods
Experimental studies were p rformed in the CICS-UBI laboratories (Health Sciences Research
Centre, University of Beira Interior, Covilhã, Portugal). The laboratories have ll the necessa y
equipment to develop the methodol gies desc ibed bel w. Centro Hospital r Univer itário d Cova da
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4.1. Sample Collection
Umbilical cord (UC) samples were obtained from normal full-term pregnancies after vaginal
delivery. All donor mothers were healthy and were under no medication, other than folic acid during
the first 21 weeks of gestation or iron supplementation throughout the gestational period. All subjects
gave their informed consent for inclusion before they participated in the study. Samples were collected
after informed consent. The experiments followed a protocol approved by the Ethics Committee
to health of Centro Hospitalar Universitário da Cova da Beira E.P.E. (No.33/2018, 18 July 2018).
Samples were resected from the proximal half of the UC (20 cm) and collected within 10 to 20 min
after delivery. The UC collected were stored at 4 ◦C for 4–24 h in sterile physiological saline solution
(PSS). Composition of PSS solution: NaCl 110 mmol/L; CaCl2 0.15 mmol/L; KCl 5 mmol/L; MgCl2
2 mmol/L; HEPES 10 mmol/L; NaHCO3 10 mmol/L; KH2PO4 0.5 mmol/L; NaH2PO4 0.5 mmol/L;
Glucose 10 mmol/L; and EDTA 0.49 mmol/L. To avoid contamination, antibiotics (penicillin, 5 U/mL,
streptomycin, 5 µg/mL and amphotericin B, 12.5 ng/mL) were added to the PSS solution. In addition,
to avoid tissue degradation, antiproteases (leupeptin, 0.45 mg/L; benzamidine, 26 mg/L; and trypsin
inhibitor, 10 mg/L) were added to the same solution.
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4.2. Arterial Contractility Experiments
The dissection and treatment of arteries were performed as described by Cairrao et al. (2008) [36].
Briefly, UC pieces were placed on glass Petri dishes containing PSS solution and the arteries were
isolated by removal of the surrounding connective tissue (Wharton’s jelly). HUA isolated were
cut into small rings (size 3–5 mm) and the vascular endothelium was mechanically removed with
a cotton bud introduced through the arterial lumen. Then, these rings were used to perform arterial
contractility experiments.
The HUA rings were placed in organ bath chambers LE01.004 (Letica, Madrid, Spain) containing
Krebs-bicarbonate solution (20 mL) at a temperature of 37 ◦C. The composition of Krebs modified
solution was NaCl 119 mmol/L, KCl 5.0 mmol/L, NaHCO3 25 mmol/L, KH2PO4 1.2 mmol/L, CaCl2
0.5 mmol/L, MgSO4 1.2 mmol/L, EDTA 0.03 mmol/L and glucose 11 mmol/L (pH 7.4). The rings were
suspended between two parallel stainless-steel wires and the tension was measured in millinewton
(mN) using isometric transducers TRI201 (Panlab SA, Madrid, Spain) connected to an ML118/D Quad
Bridge amplifier (AD Instruments, Oxford, UK), an interface Power Lab/4SP ML750 (ADInstruments)
and a computerised system with Chart 5 Power Lab software (ADInstruments). The artery rings were
continuously aerated with carbogen (95% O2 and 5% CO2), because this gas mixture allowed the CO2
pressure and pH value in the organ bath to be similar to the values in human plasma.
The artery rings were placed under a preresting tension (20–25 mN) and were subjected to
an equilibration period for 60 min. During this period, the organ bath solution was changed every
15 min. The viability of rings was tested by precontracting them with a supramaximal concentration
of 5-HT (1 µmol/L) and the rings in which a maximum contraction <10 mN were not used in the
study [36]. The vascular effect of OMC on 5-HT (1 µmol/L), His (10 µmol/L) or KCl (60 mmol/L)
contractions was evaluated: cumulative OMC concentrations (0.001, 0.01, 0.1, 1, 10 and 50 µmol/L)
were added. The OMC concentrations were chosen according to Schlumpf et al. 2001 [14].
To determine the involvement of Ca2+ channels in OMC-induced vasorelaxation, nifedipine
(Nif, a specific inhibitor of L-Type VOCC and the contractile agent KCl (60 mmol/L) (that induce
depolarisation of SMC membrane by opening L-Type VOCC) was used. After a stable contraction
with the different contractile agents, the rings were incubated with Nif (0.1 or 1 µmol/L) and the
vasorelaxation induced by OMC (0.001–50 µmol/L) was analysed.
The involvement of cyclic nucleotides in OMC-induced vasorelaxation was also investigated.
For this, sodium nitroprusside (SNP, a soluble guanylyl cyclase (sGC) stimulator) was used.
After a stable contraction with the different contractile agents, the rings were incubated with SNP (1 or
10 µmol/L) and the vasorelaxation induced by OMC (0.001–50 µmol/L) was analysed.
Control experiments with ethanol were always performed. Each experiment was conducted
in a several HUA rings from at least three different arteries. Because SNP, Nif and OMC are
photodegradable agents, all procedures were carried out in absence of light.
4.3. Cell Dissociation and Culture
Cultures of HUASMC were obtained through explants of the umbilical artery, as described by
Martin et al. (2007) [61] and Cairrao et al. (2009) [9]. All procedures were performed inside a laminar
flow chamber after aseptic procedures and using sterile materials, solutions and instruments. Briefly,
UC pieces were placed in glass Petri dishes containing PSS solution and antibiotics. HUA were isolated
from the UC pieces by removal of the surrounding connective tissue. The smooth muscle layers from
the tunica media were extracted and to avoid endothelial cell contamination, the tunica intima was
mechanically removed by gentle rubbing with a cotton bud. In this process, the circular media layer
that is in contact with the adventitia was rejected to guarantee the total removal of fibroblasts [8]. Pieces
of longitudinal media layer were washed 4 times with PSS, for 5 min each wash. This mechanical
dissociation with a Pasteur pipette allows the removal of any cells that could still be present or tissue
debris. After that, pieces were distributed in culture dishes (coated with collagen, 20 µg/cm2) and the
excess of PSS surrounding the tissue pieces was removed. Dishes were incubated (10 to 15 min) at
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37 ◦C in an atmosphere of 95% O2 and 5% CO2 to dry and, thus, facilitate the tissue pieces adsorption
on the surface. Then, culture medium was added. The composition of the cell culture medium was
DMEM-F12 containing bovine serum albumin (BSA, 0.5%), heat-inactivated foetal bovine serum (FBS,
5%), epidermal growth factor (EGF, 5 µg/mL), fibroblast growth factor (FGF, 0.5 ng/mL), heparin
(2 µg/mL), insulin (5 µg/mL) and a mixture of antibiotics: penicillin (5 U/mL), streptomycin (5 µg/mL)
and amphotericin B (12.5 ng/mL). SMC migrated from the tissue to the culture dish surface, where they
grew at 37 ◦C in an atmosphere of 95% O2 and 5% CO2. The culture medium was changed every
2–3 days to obtain confluent cultures (20–30 days). At this point (when HUASMC spread out from
the explants covering ~90–95% of the dish area), cells were trypsinised, the cell culture medium was
removed, the cells were washed with phosphate-buffered saline (PBS) and commercial trypsin-EDTA
solution (0.025%) was added to detach the cells from the dish surface. After trypsinisation, the cells
were transferred to cell culture flasks and cultured as above. Subcultures of HUASMC were performed
until the fourth passage. Cells from the different passages were used to perform PCSA experiments
(see below).
4.4. Cellular Contractility Experiments
The Planar cell surface area technique was carried out as described by our group [62], working
with vascular SMC. The PCSA is a useful technique allowing the study of changes in the cell surface
area through the image acquisition of SMC. The recorded images allow us to analyse a decrease or
an increase in cell areas that correspond to a contraction or a relaxation, respectively [62].
The HUASMC were grown in 6-well culture plates with culture medium until confluence. At this
point, cell culture medium was removed. The HUASMC were placed in culture medium without FBS
(FBS-free culture medium) and incubated (24 h) at 37 ◦C in an atmosphere of 95% O2 and 5% CO2,
once these are the required conditions for SMC to express the contractile phenotype necessary for the
study [8,9]. The composition of the FBS-free culture medium was DMEM-F12 containing bovine serum
albumin (BSA, 0.5%). After that, cells were trypsinised and plated in specific Petri dishes (coated with
collagen, 5 mg/cm2) wrapped in silver and incubated (2 h) as above. After this incubation period,
the cells were washed 4 times with PBS. The whole procedure was performed in the absence of light
due to photodegradation of OMC.
Direct observation of cells was carried out at room temperature under phase contrast with
an inverted fluorescence microscope (Zeiss Axio Observer Z1, Jena, Germany). This microscope is
equipped with an incubation system that controls temperature (maintaining the cellular viability)
and a high-speed monochrome digital camera Axio Cam Hsm (Zeiss) to take photographs of cells.
The HUASMC were incubated under different experimental conditions: firstly, 5-HT (1 µmol/L) or
His (10 µmol/L) was added and waited until the cell contraction reached its maximal response.
Then, the vascular effect of OMC on these contractions was evaluated for 50 µmol/L of OMC,
which is the concentration where maximum relaxation was achieved according to the organ bath data.
Control experiments with ethanol were always performed. Serial photographs were taken along each
experiment, specifically before and after all experimental additions. The PCSA was determined by
computerised image analysis using the Axion vision 4.8 software (Zeiss). Actual area measurement was
calculated using the supplementary “Automatic Measurement program” (Zeiss). Four to eight cells
per photograph were chosen for analysis, and a suitable sharp margin for its planimetric analysis was
always considered. In every experiment, a set of cells from only single culture and passage were used.
The same experimental protocol was repeated in cells from different passages and different cultures.
4.5. Drugs and Chemicals
All the drugs and chemicals were purchased from Sigma-Aldrich Química (Sintra, Portugal).
To create stock solutions, the different drugs were diluted to desired concentration with distilled water
or absolute ethanol. Octylmethoxycinnamate (OMC) and nifedipine (Nif) were dissolved in ethanol.
All the solutions were stored at −20 ◦C. Final solutions of OMC and ethanol control were obtained by
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dilution with Krebs solution or FBS-free culture medium. These appropriate dilutions were carried
out according to the experiment and were prepared daily. The final concentration of ethanol never
exceeded 0.05% in all experiments.
4.6. Statistical Analysis
For statistical analysis of arterial contractility experiments, the isometric tension measurements
were expressed in millinewton (mN) of force elicited by the artery in the presence of vasoconstrictor
drugs (5-HT, His or KCl 60 mmol/L). The relaxant responses induced by OMC were expressed as a %
of reduction of the maximal contraction induced by each contractile agent. All results were expressed
as mean ± standard deviation (S.D.) of the number (n) of rings used.
Regarding statistical analysis of cellular contractility experiments, the actual area measurements
were expressed in micrometres2 (µm2) of area achieved by the cell in the presence of vasoconstrictor
drugs (5-HT or His). The relaxant responses induced by OMC were expressed as a % of reduction
of the maximal area induced by each contractile agent. Results were expressed as mean ± standard
deviation (S.D.) of the number (n) of the human umbilical arteries used to obtain the cells.
The software SigmaStat Statistical Analysis System version 3.5 (2006) was used to perform
statistical treatment of data, and the graphic design was achieved with Software Origin 8.5.1.
Presence of a normal distribution was elucidated using Kolmogorov–Smirnov test. A Student’s
t-test was used to analyse the statistical significance between two groups. In comparison among
multiple groups, one-way ANOVA method followed by Tukey’s post-hoc tests or the corresponding
nonparametric method (Kruskal–Wallis) followed by Dunn’s post-hoc tests were used to determine
significant differences between the means. For all tests, a p-value less than 0.05 was considered
statistically significant.
5. Conclusions
In conclusion, this work represents a whole new and promising research field that remains almost
entirely unexplored. Further studies are needed to increase the knowledge about the effects of OMC at
the vascular level. In addition to the human studies, it is important to study its effects on other species
and arteries to uncover the cardiovascular toxicity of this UV-B filter. Given its wide presence in the
environment and its potentially adverse effects on human health, studying human exposure to OMC
may lead to a better understanding of the role of OMC in cardiovascular diseases and the identification
of molecular pathways that can be targeted for the prevention and treatment of these diseases.
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